Bio-Techne Corporation is a biotech company developing new medicines.
Bio-Techne Corporation (TECH) is expected to report earnings on Wednesday, November 4, 2026, before the open. Estimated release time 06:30 ET. Consensus EPS estimate is $0.44.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-12 | Jun 2026 qtr | $0.52 | $0.52 | +0.2% | $321.19M |
| 2026-05-06 | Mar 2026 qtr | $0.55 | $0.53 | -3.6% | $311.42M |
| 2026-02-04 | Dec 2025 qtr | $0.43 | $0.46 | +7.0% | $295.88M |
| 2025-11-05 | Sep 2025 qtr | $0.42 | $0.36 | -14.6% | $286.56M |
| 2025-08-06 | Jun 2025 qtr | — | $-0.11 | — | $316.96M |
| 2025-05-08 | Mar 2025 qtr | $0.51 | $0.56 | +10.2% | $316.18M |
| 2025-02-06 | Dec 2024 qtr | $0.39 | $0.42 | +8.8% | $297.03M |
| 2024-10-30 | Sep 2024 qtr | $0.38 | $0.42 | +10.5% | $289.46M |
TECH has beaten consensus EPS in 5 of its last 7 scored quarters.
See TECH on the live calendar →